In-depth: Breakthrough hepatitis C cures slowly becoming more widely available in South Africa

Posted in: Access to Medicines, Latest

Almost a decade after they were first proven to be safe and highly effective, game-changing medicines to cure hepatitis C are finally becoming more widely available in South Africa. But not all the regulatory and other challenges behind the delay have yet been overcome and, as a result, access remains relatively limited for now. Catherine Tomlinson reports.

In-depth: Breakthrough hepatitis C cures slowly becoming more widely available in South Africa

Analysis: How well did SAHPRA do in 2022?

Posted in: Access to Medicines, Healthcare system, Latest

The South African Health Products Regulatory Authority has often made the headlines in recent years – be it in relation to COVID-19 vaccines, access to ivermectin, the approval of an HIV prevention injection, or most recently the clearing of inherited backlogs. Catherine Tomlinson assesses the state of South Africa’s medicines regulator as 2022 draws to a close.